Beta2-adrenergic receptor gene polymorphisms as systemic determinants of healthy aging in an evolutionary context.

dc.contributor.author

Kulminski, Alexander M

dc.contributor.author

Culminskaya, Irina

dc.contributor.author

Ukraintseva, Svetlana V

dc.contributor.author

Arbeev, Konstantin G

dc.contributor.author

Land, Kenneth C

dc.contributor.author

Yashin, Anatoli I

dc.coverage.spatial

Ireland

dc.date.accessioned

2017-06-07T19:39:20Z

dc.date.available

2017-06-07T19:39:20Z

dc.date.issued

2010-05

dc.description.abstract

The Gln(27)Glu polymorphism but not the Arg(16)Gly polymorphism of the beta2-adrenergic receptor (ADRB2) gene appears to be associated with a broad range of aging-associated phenotypes, including cancers at different sites, myocardial infarction (MI), intermittent claudication (IC), and overall/healthy longevity in the Framingham Heart Study Offspring cohort. The Gln(27)Gln genotype increases risks of cancer, MI and IC, whereas the Glu(27) allele or, equivalently, the Gly(16)Glu(27) haplotype tends to be protective against these diseases. Genetic associations with longevity are of opposite nature at young-old and oldest-old ages highlighting the phenomenon of antagonistic pleiotropy. The mechanism of antagonistic pleiotropy is associated with an evolutionary-driven advantage of carriers of a derived Gln(27) allele at younger ages and their survival disadvantage at older ages as a result of increased risks of cancer, MI and IC. The ADRB2 gene can play an important systemic role in healthy aging in evolutionary context that warrants exploration in other populations.

dc.identifier

https://www.ncbi.nlm.nih.gov/pubmed/20399803

dc.identifier

S0047-6374(10)00072-2

dc.identifier.eissn

1872-6216

dc.identifier.uri

https://hdl.handle.net/10161/14883

dc.language

eng

dc.publisher

Elsevier BV

dc.relation.ispartof

Mech Ageing Dev

dc.relation.isversionof

10.1016/j.mad.2010.04.001

dc.subject

Adolescent

dc.subject

Adult

dc.subject

Aged

dc.subject

Aging

dc.subject

Alleles

dc.subject

Amino Acid Substitution

dc.subject

Cardiovascular Diseases

dc.subject

Child

dc.subject

Child, Preschool

dc.subject

Evolution, Molecular

dc.subject

Female

dc.subject

Health

dc.subject

Humans

dc.subject

Longevity

dc.subject

Male

dc.subject

Middle Aged

dc.subject

Polymorphism, Genetic

dc.subject

Receptors, Adrenergic, beta-2

dc.subject

Risk

dc.subject

Young Adult

dc.title

Beta2-adrenergic receptor gene polymorphisms as systemic determinants of healthy aging in an evolutionary context.

dc.type

Journal article

duke.contributor.orcid

Arbeev, Konstantin G|0000-0002-4195-7832

duke.contributor.orcid

Land, Kenneth C|0000-0002-9551-7314

pubs.author-url

https://www.ncbi.nlm.nih.gov/pubmed/20399803

pubs.begin-page

338

pubs.end-page

345

pubs.issue

5

pubs.organisational-group

Center for Population Health & Aging

pubs.organisational-group

Duke

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Duke Population Research Center

pubs.organisational-group

Duke Population Research Institute

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

Sanford School of Public Policy

pubs.organisational-group

School of Medicine

pubs.organisational-group

Social Science Research Institute

pubs.organisational-group

Sociology

pubs.organisational-group

Staff

pubs.organisational-group

Trinity College of Arts & Sciences

pubs.organisational-group

University Institutes and Centers

pubs.publication-status

Published

pubs.volume

131

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Beta2-adrenergic receptor gene polymorphisms as systemic determinants of healthy aging in an evolutionary context..pdf
Size:
503.45 KB
Format:
Adobe Portable Document Format